Back to News
Market Impact: 0.3
Zimmer Biomet Holdings, Inc. Reports Third Quarter 2026 Financial Results and Updates Full-Year Guidance
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Zimmer Biomet reported third-quarter net sales of $2.063 billion for the period ended September 30, 2026, up 3.1% year over year and 3.7% on a constant-currency basis. The available report provides no earnings comparison or outlook information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
ZBH0.35
More News
- Stifel raises Zimmer Biomet stock price target on strong quarter
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh
- Snap shares fall over 10% on third-quarter earnings miss
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT